Treatment of Female Hair Loss (Androgenetic Alopecia)

First-Line Treatment Approach

The American Academy of Dermatology recommends topical minoxidil as the cornerstone of treatment for female androgenetic alopecia, which must be continued indefinitely to maintain hair growth benefits 1

The American Academy of Periodontology confirms that platelet-rich plasma (PRP) combined with minoxidil produces the highest increase in hair density compared to either treatment alone, making this the optimal strategy when resources permit 1
PRP treatment protocol involves an initial phase of 3-5 treatment sessions spaced exactly 1 month apart, followed by a maintenance phase of 1 session every 6 months, with 5-7 mL of PRP per session injected at 0.05-0.1 mL/cm² 1

The American Academy of Dermatology recommends evaluating treatment response using multiple objective measures, including standardized before-and-after photographs, trichoscopy to measure hair density and diameter, hair pull tests, and patient self-assessment questionnaires 1, 2
Schedule formal evaluation at 12 months for PRP combination therapy, and at 3 months initially for other treatments, with meaningful changes potentially taking 12-24 months 1, 3

Increased hair density per cm², increased hair shaft diameter, decreased proportion of telogen hairs, and improved patient satisfaction scores are indicators of a positive response to treatment 1, 2

Inadequate follow-up, stopping treatment prematurely, discontinuing successful therapy, and using unproven supplements without documented deficiencies can lead to suboptimal outcomes 1, 4

Addressing the psychological impact of hair loss through counseling and cosmetic camouflage options is essential, and hair transplantation should be considered for advanced cases resistant to medical treatment 3